HIV infection and secondary causes of immunodeficiency Flashcards

1
Q

classification of immune deficiencies

A

far more common than primary immune deficiencies

malnutrition (most common around the world)

ID: HIV

environmental stress

age extremes: prematurity and old age

surgery and trauma splenectomy

immuno suppressive drgs

genetic and metabolic diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

immune deficiencies exhibit diverse clinical features (4)

A

infections = severe, persistent, recurrent, unusual

autoimmune conditions (cytopaenias very common in 1o and 2o immune deficiencies) and allergic disease

persistent inflammation

cancer (viral associated EBV, HHV-8)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

common causes of 2o immune deficiencies

A

malnutrition (common cause WW)

measles = immune defect lasts months to years, increased morbidity and mortalitty

TB = inflammatory immune re-constitution syndrome

HIV = residual immune dysfunction persists despite successful ART

SATS-CoV-2 infection = multi-factorial causes, virus, drugs, co-morbidities (renal disease and DM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

types of drugs that cause immune deficiency

A

small molecules

  • glucocorticoids and mineralocorticoids
  • cytotoxic agents: methotrexate, mycophenolate, cyclophosphamide and azathioprine
  • calcineurin inhibitors: cyclosporine and tacrolimus
  • antiepileptic drugs: phenytoin, carbamazepin, levetiracetam
  • DMARD: sulphasalazine, leflunomide

JAK inhibitors

  • tofacitinib, upadacitinib, ruxolitinib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

note done biologics and cellular therapies causes of immune deficiency

A

biologics = anti-CD20, anti-TNF-a protein and receptor antagonists

cellular therapy = anti-CD19-/Tc therapy

  • Antibody deficiency and bacterial/viral infections are observed with rituximab and other anti-CD20 agents
  • Risk of infection increased with repeated courses and in patient in patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

haematological cancers as causes of 2o immune deficiency

A

B and plasma cell cancers (antibody deficiency syndromes are most common)

chemo, biological therapy, radiotherapy

Bc lymphoproliferative disorders

  • Multiple myeloma
  • CLL
  • NHL
  • monoclonal gammopathy of uncertain signficance

Good’s syndrome (thymoma and antibody deficiency)

  • T and B cell (absent) defect
  • CMV PJP and muco-cutaneuous candida
  • Autoimmune disease (Pure red cell aplasia, Myasthenia gravis, Lichen planus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

evaluation of secondary immune deficiency: question to ask in history

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

FISH for an immunodeficiency

A

FBC

  • Hb <10g/L
  • neutrophil count
  • lymphocyte count
  • platelet count

Immunoglobulins (IgG/A/M/E)

Serum complement (C3,C4) = for serum complex disease, lupus

HIV test (18-80 years)

Strategy will pick up to 85% of all immune defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

front line ix for immune deficiency: chemistry

A

renal and liver profile

calcium and bone profile

total protein and albumin

urine protein/Cr ratio

serum

protein electorpohoresis

serum free light chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

front line ix for immune deficiency: serum Ig

A
  1. check lab issues age-releted reference intervals especially for children
  2. Ig profile helpful in diagnosis
  • isolated IgG reduction = protein loosing enteropathy, prednisolone >10mg/day
  • reduction IgG and IgM = monitor for B cell neoplasm, hx of exposure to rituximab
  • reduction in IgG and IgA = primary antibody deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

front line ix for immune deficiency: electrophoresis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

second line test to ix for immune deficiency: vaccinae antibodies

A

measure concentration of vaccine antibodies

  • tetanus toxoid = protein antigen
  • pneumovax vaccine = carbohydrate antigen (all 23 serotypes or to individual pneumococcal serotypes)

if vaccine antibody levels low = offer test immunisation with pneumovax II and tetanus to ix immune function

failure to respond to vaccination is part of diagnostic criteria for a nymber of 1o antibody deficiency syndromes and is a criteria for receipt of IgG replacement theerapy for 2o antibdoy defiicency syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NOT DONE second line test to ix for immune deficiency:

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

mx of 2o immune deficiency

A

tx underlying cause

advise on measures to reduce exposure to infection

immunise against resp viruses and bacteria and offer vaccines to household contacts

education to tx bacterial infections promplty: may require high and longer therapies courses

prophylactic abx for confirmed recurrent bacterial infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

IgG replacement therapy for 2o antibody deficiency sundromes

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HIV-1 virology

A
17
Q

5 characteristic features of the immunology of HIV-1 infection

A
18
Q

diagnosis of HIV-1 infection

A
19
Q

baseline ix hiv

A
20
Q

evaluation and mx of HIV-1 infection

A
21
Q

cd4+ cell count and opportunistic infections

A
22
Q

HIV-1 specific tests

A
23
Q

standard ART in UK

A
  • 2 NRTI and 1 NNRTI or 2NRTI and 1 Integrase inhibitor are standard first line anti-HIV-1 treatments in the UK
  • Considerable efforts in last 5-10 years to combine different ART drugs in a single pill formulations to improve adherence to therapy
  • Drug toxicity rather than virological failure is the main reason why HIV-1 patients change HIV therapy
  • It is safer to continue to take ART rather than interrupt anti-HIV treatment course (SMART study)
24
Q

monitoring individuals on ART

A

Check for compliance with drug therapy and for adverse side effects

Regular HIV-1 viral load

Monitor liver, renal, bone and lipid toxicity

CD4 T cell monitoring not needed for counts more than 350cells/ul

Assess cardiovascular and osteoporosis risk

25
Q
A